Boric Acid for Recurrent Vulvovaginal Candidiasis: The Clinical Evidence
Authors:
- 1 August 2011
- journal article
- research article
- Published by SAGE Publications in Journal of Women's Health
- Vol. 20 (8) , 1245-1255
Abstract
Background: Recurrent vulvovaginal candidiasis (VVC) remains a challenge to manage in clinical practice. Recent epidemiologic studies indicate that non-albicans Candida spp. are more resistant to conventional antifungal treatment with azoles and are considered as causative pathogens of vulvovaginal candidiasis. Methods: We searched PubMed and Scopus for studies that reported clinical evidence on the intravaginal use of boric acid for vulvovaginal candidiasis. Results: We identified 14 studies (2 randomized clinical trials [RCTs], 9 case series, and 4 case reports) as eligible for inclusion in this review. Boric acid was compared with nystatin, terconazole, flucytosine, itraconazole, clotrimazole, ketoconazole, fluconazole, buconazole, and miconazole; as monotherapy, boric acid was studied in 7 studies. The mycologic cure rates varied from 40% to 100% in patients treated with boric acid; 4 of the 9 included case series reported statistically significant outcomes regarding cure (both mycologic and clinical) rates. None of the included studies reported statistically significant differences in recurrence rates. Regarding the adverse effects caused by boric acid use, vaginal burning sensation (Conclusions: Our findings suggest that boric acid is a safe, alternative, economic option for women with recurrent and chronic symptoms of vaginitis when conventional treatment fails because of the involvement of non-albicans Candida spp. or azole-resistant strains.Keywords
This publication has 38 references indexed in Scilit:
- Local Treatment of Vulvovaginal CandidosisDrugs, 2008
- Comprehensive review of conventional and non‐conventional methods of management of recurrent vulvovaginal candidiasisAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2007
- Teratogenic effects of vaginal boric acid treatment during pregnancyInternational Journal of Gynecology & Obstetrics, 2006
- Vulvovaginitis due to fluconazole resistant Candida albicans following self treatment with non-prescribed triazolesSexually Transmitted Infections, 2002
- Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasisObstetrics & Gynecology, 2002
- Over-the-counter and alternative medicines in the treatment of chronic vaginal symptomsObstetrics & Gynecology, 1997
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Evolving Pathogens in Vulvovaginal Candidiasis: Implications for Patient CareThe Journal of Clinical Pharmacology, 1992
- Pathogenesis and Treatment of Recurrent Vulvovaginal CandidiasisClinical Infectious Diseases, 1992
- Boric acid poisoningJournal of the American Academy of Dermatology, 1982